SCHEMBL2967239

SCHEMBL2967239

CCOCC(O)(Cl)OCC

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17140328 0.76
SCHEMBL16817095 0.76
SCHEMBL9137562 0.74
SCHEMBL6238385 0.74 ALDH1A1 (0.33) ALDH1A1
SCHEMBL7179939 0.74 ALDH1A1 (0.33) ALDH1A1
SCHEMBL6887437 0.72 ALDH1A1 (0.32) ALDH1A1
SCHEMBL8371347 0.72
SCHEMBL10711783 0.72 ALDH1A1 (0.32) ALDH1A1
SCHEMBL9048508 0.70 ALDH1A1 (0.31) ALDH1A1
SCHEMBL7653128 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12053738-B2 Process for increased selectivity and capacity for hydrogen sulfide capture from acid gases ExxonMobil Technology and Engineering Company (US) 2024-08-06 US disclosed
CN-108472575-B Method for increasing selectivity and capacity for capturing hydrogen sulfide from acid gas 埃克森美孚研究工程公司 2022-07-12 CN disclosed
US-20220126235-A1 Process for Increased Selectivity and Capacity for Hydrogen Sulfide Capture from Acid Gases ExxonMobil Technology and Engineering Company 2022-04-28 US disclosed
US-11185813-B2 Process for increased selectivity and capacity for hydrogen sulfide capture from acid gases EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2021-11-30 US disclosed
CN-113382754-A Compounds, compositions, methods and uses for treating cancer and immune disorders IL-2RX公司 2021-09-10 CN disclosed
US-20210252160-A1 COMPOUNDS, COMPOSITIONS, METHODS, AND USES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS IL-2RX 2021-08-19 US disclosed
EP-2139925-B1 CROSS-LINKED LATEX PARTICULATES HEWLETT PACKARD DEVELOPMENT CO (US) 2018-12-05 EP disclosed
EP-3397370-A1 PROCESS FOR INCREASED SELECTIVITY AND CAPACITY FOR THE HYDROGEN SULFIDE CAPTURE FROM ACID GASES Exxonmobil Research And Engineering Company (US) 2018-11-07 EP disclosed
CN-108472575-A Increase the method from the selectivity and capacity of acid gas capture hydrogen sulfide 埃克森美孚研究工程公司 2018-08-31 CN disclosed
US-9962644-B2 Process for increased selectivity and capacity for hydrogen sulfide capture from acid gases EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2018-05-08 US disclosed
EP-1853739-A1 FUNGICIDAL COMPOSITIONS AND METHODS USING CYANODITHIOCARBIMATES BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2007-11-14 EP disclosed
US-20070225488-A1 MAGNETIC PARTICLES AND METHODS OF PRODUCING COATED MAGNETIC PARTICLES SKOLD TECHNOLOGIES (US) 2007-09-27 US disclosed
US-20070161811-A1 Fungicidal compositions and methods using cyanodithiocarbimates BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2007-07-12 US disclosed
WO-2007021462-A2 ALKYLAMINO ALKYLOXY (ALCOHOL) MONOALKYL ETHER FOR ACID GAS SCRUBBING PROCESS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2007-02-22 WO disclosed
US-7169618-B2 Magnetic particles and methods of producing coated magnetic particles SKOLD TECHNOLOGY (US) 2007-01-30 US disclosed
US-7157017-B2 Fungicidal compositions and methods using cyanodithiocarbimates BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2007-01-02 US disclosed
WO-2006096159-A1 FUNGICIDAL COMPOSITIONS AND METHODS USING CYANODITHIOCARBIMATES BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2006-09-14 WO disclosed
US-20050109975-A1 Fungicidal compositions and methods using cyanodithiocarbimates BUCKMAN LABORATORIES INTERNATIONAL, INC. 2005-05-26 US disclosed
US-20020000398-A1 Magnetic particles and methods of producing coated magnetic particles SKOLD TECHNOLOGY 2002-01-03 US disclosed
US-4894178-A HYDROGEN SULFIDE ABSORPTION WITH TERT-BUTYL AMINO ETHERS EXXON RESEARCH AND ENGINEERING COMPANY (US) 1990-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210252160-A1 COMPOUNDS, COMPOSITIONS, METHODS, AND USES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS TNFRSF9, EGFR, NGFR ALDH1A1 4499/4885
US-20070161811-A1 Fungicidal compositions and methods using cyanodithiocarbimates TYR, CBR3, TH ALDH1A1 2610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.